In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug sorted by
relevance

Admin28.07.2021

In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug

5506
Admin25.09.2021

In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor

8905
Admin13.09.2021

In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor

8100
Admin04.08.2021

Igrov 1 Human Ovarian Adenocarcinoma Cell Lines | ATCC | Bioz

8800
Admin19.07.2021

Remarkable in vitro and in vivo activity of IMGN853, an antibody-drug conjugate targeting folate

4007
Admin12.08.2021

In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor

87010
Admin16.07.2021

In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor

4808
Admin27.07.2021

(PDF) Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug

2909
Admin27.07.2021

IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted

70010
Admin22.07.2021

IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted

Admin26.09.2021

Dual-drug ADC activity on in vitro (A) and in vivo (B) models that have | Download Scientific

5502
Admin09.08.2021

Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2

69010
Admin09.10.2021

A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity | Molecular Cancer

2606
Admin09.08.2021

Remarkable in vitro and in vivo activity of IMGN853, an antibody-drug conjugate targeting folate

6309
Admin03.10.2021

(PDF) Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug

1301
Admin24.07.2021

Christian BRAND | PostDoc Position | Dipl. Chem, Dr. rer. nat. | Memorial Sloan Kettering Cancer

8606
Admin03.08.2021

Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate | EJNMMI

4901
Admin02.08.2021

In vitro antibody stability. The anti-Her2 ADC antibodies were | Download Scientific Diagram

Admin23.09.2021

Preclinical Antitumor Activity of a Novel Anti-c-KIT Antibody-Drug Conjugate against Mutant and

5805
Admin08.10.2021

In vitro and in vivo antiproliferative effects of | Download Scientific Diagram

107
Admin27.08.2021

(PDF) Maytansine-bearing antibody-drug conjugates induce in vitro hallmarks of immunogenic cell

1808